top of page

My Story

Originally from the Democratic Republic of Congo, Yves T. Mukanya is the Supervisor for Quality Assurance at Thermo Fisher Scientific in Cambridge, Massachusetts after working for two years as a chemist on the production of the COVID-19 vaccine at Moderna in Norwood, Massachusetts. At the beginning of his career, Yves worked as a Research Assistant for Beth Israel and Deaconess Medical Center in Boston, Massachusetts. He was involved in researching whether variations on a specific gene predispose African Americans to diabetes and or renal disease. From this research, a paper titled “Functional ENTPD1 Polymorphisms in African Americans With Diabetes and End-Stage Renal Disease” was published in 2009 by the journal Diabetes from the American Diabetes Association.  


Yves has worked for various pharmaceutical companies including Sanofi Genzyme where his focus was on Microbiology. After 8 years with the company, his work continues to have a lasting impact on the lives of patients suffering from rare diseases (Gaucher disease, Fabry disease, Pompe disease, Mucopolysaccharidosis I, Sphingomyelinase deficiency), neurological diseases (Multiple Sclerosis), various Cancers, rare blood disorders (Hemophilia), and immunological diseases (Atopic dermatitis, Asthma, pulmonary disease). 


In addition to his work in the pharmaceutical industry, Yves earned his Master’s degree from Johnson and Wales University in Mental Health Counseling in 2022 and has been working as a therapist in Providence, Rhode Island. His professional goal in this area is to focus on helping teens, adults, and couples through counsel, all who may be dealing with stress, depression, trauma, or low self-esteem.

Check out my Instagram for more content and upcoming announcements!

  • Instagram

Recent Speaking Engagements

Massasoit Community College Black History Month Panel: "Unsung Heroes"
Yves was recently invited to speak on his career journey and how he is overcoming obstacles to becoming a leader in the mental health field. 

Brockton, MA  |  February 2023

bottom of page